Breaking News Instant updates and real-time market news.

JAZZ

Jazz Pharmaceuticals

$179.82

3.36 (1.90%)

16:05
08/07/18
08/07
16:05
08/07/18
16:05

Jazz Pharmaceuticals reports Q2 adjusted EPS $3.49, consensus $3.23

Reports Q2 revenue $500M, consensus $469.62M.

  • 07

    Aug

  • 07

    Aug

  • 27

    Oct

  • 20

    Dec

JAZZ Jazz Pharmaceuticals
$179.82

3.36 (1.90%)

07/13/18
WELS
07/13/18
NO CHANGE
Target $182
WELS
Outperform
Jazz 'confident' in defending Xyrem in District Court, says Wells Fargo
Following news that the U.S. Court of Appeals for the Federal Circuit affirmed a series of rulings in favor of Amneal Pharmaceuticals (AMRX) that patents owned by Jazz Pharmaceuticals (JAZZ) related to its Xyrem drug are invalid, Wells Fargo analyst David Maris tells investors in a research note that he spoke with Jazz this morning and they said they "feel confident" in defending Xyrem in the District Court should the case go to trial. Additionally, Jazz, which said a trial date has not yet been set, said they have now settled with 8 out of 9 of the District Court challenges. Maris believes the reaction today is "overdone," as Jazz still has a strong portfolio to defend Xyrem and the company has shown a clear willingness to settle.
07/16/18
PIPR
07/16/18
NO CHANGE
Target $211
PIPR
Overweight
Jazz court ruling does not threaten Xyrem durability, says Piper Jaffray
A federal appellate court on Friday affirmed that certain claims surrounding a number of patents covering Jazz Pharmaceuticals' Xyrem REMS program are invalid, Piper Jaffray analyst David Amsellem tells investors in a research note. The analyst would not view the decision as a threat to the durability of Xyrem out to 2023. He continues to believe that Jazz's visibility into earnings growth in the double-digits is high, owing to contribution from newer products. Amsellem believes the company has "significant room for further value creation" and keeps an Overweight rating on Jazz with a $211 price target.
07/16/18
CANT
07/16/18
NO CHANGE
Target $203
CANT
Overweight
Cantor sees 'meaningful upside' in shares of Jazz Pharmaceuticals
Cantor Fitzgerald analyst William Tanner sees "meaningful upside" in shares of Jazz Pharmaceuticals from current levels. The analyst views recent legal developments as positive, "on balance," and thinks any announcement on the business development front "could be a major incremental driver of positive sentiment." He reiterates an Overweight rating on Jazz with a $203 price target.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).

TODAY'S FREE FLY STORIES

KSS

Kohl's

$64.45

-6.3 (-8.90%)

07:29
11/21/18
11/21
07:29
11/21/18
07:29
Recommendations
Kohl's analyst commentary  »

Kohl's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLC

Taiwan Liposome

$0.00

(0.00%)

07:28
11/21/18
11/21
07:28
11/21/18
07:28
Syndicate
Taiwan Liposome 3.75M share Secondary priced at $5.80 »

The deal size was cut to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

KSS

Kohl's

$64.45

-6.3 (-8.90%)

07:28
11/21/18
11/21
07:28
11/21/18
07:28
Recommendations
Kohl's analyst commentary  »

Kohl's faces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$183.74

-2.95 (-1.58%)

07:26
11/21/18
11/21
07:26
11/21/18
07:26
Recommendations
McDonald's analyst commentary  »

McDonald's price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.23

-0.54 (-5.53%)

, DNSKY

Danske Bank

$0.00

(0.00%)

07:25
11/21/18
11/21
07:25
11/21/18
07:25
Periodicals
Deutsche exec says bank had limited need to know of Danske details, Reuters says »

Deutsche Bank's (DB)…

DB

Deutsche Bank

$9.23

-0.54 (-5.53%)

DNSKY

Danske Bank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.10

-8.7 (-4.68%)

07:23
11/21/18
11/21
07:23
11/21/18
07:23
Periodicals
Foxconn, biggest iPhone assembler, cutting expenses and jobs, Bloomberg reports »

Foxconn Technology Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

RP

RealPage

$45.77

0.17 (0.37%)

07:23
11/21/18
11/21
07:23
11/21/18
07:23
Upgrade
RealPage rating change  »

RealPage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$46.10

-2.69 (-5.51%)

, NKE

Nike

$71.13

-1.39 (-1.92%)

07:23
11/21/18
11/21
07:23
11/21/18
07:23
Recommendations
Foot Locker, Nike analyst commentary  »

Foot Locker price target…

FL

Foot Locker

$46.10

-2.69 (-5.51%)

NKE

Nike

$71.13

-1.39 (-1.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

HNI

HNI Corporation

$36.97

-1.35 (-3.52%)

07:21
11/21/18
11/21
07:21
11/21/18
07:21
Conference/Events
HNI Corporation management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

HMST

HomeStreet

$25.24

-0.6 (-2.32%)

07:20
11/21/18
11/21
07:20
11/21/18
07:20
Conference/Events
HomeStreet management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

07:20
11/21/18
11/21
07:20
11/21/18
07:20
Periodicals
Amazon opens Spanish pop-up store, Reuters reports »

Amazon opened its first…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

07:20
11/21/18
11/21
07:20
11/21/18
07:20
General news
FX Update: The Dollar has traded mixed »

FX Update: The Dollar has…

WIX

Wix.com

$86.16

1.13 (1.33%)

07:19
11/21/18
11/21
07:19
11/21/18
07:19
Upgrade
Wix.com rating change  »

Wix.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$156.08

-4.16 (-2.60%)

07:17
11/21/18
11/21
07:17
11/21/18
07:17
Downgrade
Ecolab rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

CMCM

Cheetah Mobile

$8.54

-0.22 (-2.51%)

07:17
11/21/18
11/21
07:17
11/21/18
07:17
Earnings
Breaking Earnings news story on Cheetah Mobile »

Cheetah Mobile sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CMCM

Cheetah Mobile

$8.54

-0.22 (-2.51%)

07:17
11/21/18
11/21
07:17
11/21/18
07:17
Earnings
Cheetah Mobile reports Q3 non-GAAP EPS 19c, consensus 17c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NVDA

Nvidia

$149.14

4.48 (3.10%)

07:16
11/21/18
11/21
07:16
11/21/18
07:16
Periodicals
Nvidia to provide AI platform for Chinese EV startups, Reuters reports »

Nvidia has signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

HCSG

Healthcare Services

$44.20

0.31 (0.71%)

07:16
11/21/18
11/21
07:16
11/21/18
07:16
Conference/Events
Healthcare Services management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

GMDA

Gamida Cell

$9.50

(0.00%)

07:14
11/21/18
11/21
07:14
11/21/18
07:14
Initiation
Gamida Cell initiated  »

Gamida Cell initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

NSANY

Nissan

$0.00

(0.00%)

07:13
11/21/18
11/21
07:13
11/21/18
07:13
Periodicals
Nissan chairman Carlos Ghosn to be detained for 10 days, Reuters reports »

Tokyo District Court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMDA

Gamida Cell

$9.50

(0.00%)

07:11
11/21/18
11/21
07:11
11/21/18
07:11
Initiation
Gamida Cell initiated  »

Gamida Cell initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

SYBT

S.Y. Bancorp

$31.41

-0.5 (-1.57%)

07:08
11/21/18
11/21
07:08
11/21/18
07:08
Hot Stocks
S.Y. Bancorp CFO Nancy Davis to retire »

Stock Yards Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

  • 04

    Dec

TGT

Target

$69.05

-8.08 (-10.48%)

07:08
11/21/18
11/21
07:08
11/21/18
07:08
Recommendations
Target analyst commentary  »

Target margin concerns…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

FL

Foot Locker

$46.10

-2.69 (-5.51%)

07:07
11/21/18
11/21
07:07
11/21/18
07:07
Recommendations
Foot Locker analyst commentary  »

Barclays remains bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

07:05
11/21/18
11/21
07:05
11/21/18
07:05
Periodicals
France, Japan keen to pursue Renault-Nissan consolidation, Reuters reports »

French Finance Minister…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.